LEADER 12 HOUR NASAL DECONGESTANT (pseudoephedrine hydrochloride) tablet, film coated, extended release [Cardinal Health 110, LLC. dba Leader]
Updated Date: Fri, 27 Feb 2026 00:00:00 EST
Updated Date: Fri, 27 Feb 2026 00:00:00 EST
Updated Date: Fri, 27 Feb 2026 00:00:00 EST
The U.S. FDA approved Allurion Technologies Inc.’s premarket application for its swallowable gastric balloon system, which features its Smart Capsule,
Updated Date: Thu, 26 Feb 2026 00:00:00 EST
Updated Date: Wed, 25 Feb 2026 00:00:00 EST
Updated Date: Wed, 25 Feb 2026 00:00:00 EST
Updated Date: Tue, 24 Feb 2026 00:00:00 EST
Updated Date: Tue, 24 Feb 2026 00:00:00 EST